Patients with localized non-small cell lung cancer miss out on curative surgery with distance from specialist care

ANZ Journal of Surgery

Volumn 85, Issue 9, 2015, Pages 658-663

  Tracey, Elizabeth ^a   Mccaughan, Brian ^b   Badgery Parker, Tim ^a   Young, Jane ^a   Armstrong, Bruce K ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Access to health services; Cancer registry; Data linkage; Distance to care; Lung neoplasm; Surgery

Indexed keywords

ADOLESCENT; ADULT; AGED; CANCER STAGING; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIAL; FEMALE; HEALTH CARE DELIVERY; HEALTH SURVEY; HUMAN; LUNG NEOPLASMS; LUNG RESECTION; MALE; MIDDLE AGED; MORBIDITY; MULTICENTER STUDY; NEW SOUTH WALES; ODDS RATIO; ORGANIZATION AND MANAGEMENT; PROCEDURES; PUBLIC HOSPITAL; REGISTER; SURVIVAL RATE; TRENDS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HEALTH SERVICES ACCESSIBILITY; HOSPITALS, PUBLIC; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MORBIDITY; NEOPLASM STAGING; NEW SOUTH WALES; ODDS RATIO; PNEUMONECTOMY; POPULATION SURVEILLANCE; REGISTRIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84940598606     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/ans.12855     Document Type: Article

References (36)

1. Tracey E, Kerr T, Dobrovic A, Currow D Cancer in NSW: Incidence and Mortality Report 2008. Sydney: Cancer Institute NSW, 2010.
2. Walters S, Maringe C, Coleman MP etal. Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004-2007. Thorax 2013; 68: 551-564.
3. Coleman M, Forman D, Bryant H etal. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 2011; 377: 127-138.
4. National Health and Medical Research Council. Clinical Practice Guidelines for the Prevention, Diagnosis and Management of Lung Cancer. Canberra: Australian Government, 2004.
5. Rich AL, Tata LJ, Free CM etal. Inequalities in outcomes for non-small cell lung cancer: the influence of clinical characteristics and features of the local lung cancer service. Thorax 2011; 66: 1078-1084.
6. Luchtenborg M, Riaz SP, Coupland VH etal. High procedure volume is strongly associated with improved survival after lung cancer surgery. J. Clin. Oncol. 2013; 31: 3141-3146.
7. Tieu B, Schipper P. Specialty matters in the treatment of lung cancer. Sem. Thorac. Cardiovasc. Surg. 2012; 24: 99-105.
8. Freeman RK, Dilts JR, Ascioti AJ, Giannini T, Mahidhara RJ. A comparison of quality and cost indicators by surgical specialty for lobectomy of the lung. J. Thorac. Cardiovasc. Surg. 2013; 145: 68-73, discussion 73-4.
9. Crawford SM, Sauerzapf V, Haynes R, Zhao H, Forman D, Jones AP. Social and geographical factors affecting access to treatment of lung cancer. Br. J. C. 2009; 101: 897-901.
10. Jones AP, Haynes R, Sauerzapf V, Crawford SM, Zhao H, Forman D. Travel times to health care and survival from cancers in Northern England. Eur. J. Cancer 2008; 44: 269-274.
11. Jones AP, Haynes R, Sauerzapf V, Crawford SM, Zhao H, Forman D. Travel time to hospital and treatment for breast, colon, rectum, lung, ovary and prostate cancer. Eur. J. Cancer 2008; 44: 992-999.
12. Simonella L, O'Connell D, Vinod S etal. No improvement in lung cancer care: the management of lung cancer in 1996 and 2002 in New South Wales. Intern. Med. J. 2009; 39: 453-458.
13. Vinod S, Hui A, Esmaili N, Hensley M, Barton M. Comparison of patterns of care in lung cancer in three area health services in New South Wales, Australia. Internal Med. J. 2004; 34: 677-683.
14. Vinod SK, O'Connell DL, Simonella L etal. Gaps in optimal care for lung cancer. J. Thorac. Oncol. 2008; 3: 871-879.
15. Tracey E, Ling L, Baker D, Dobrovic A, Bishop J Cancer in New South Wales: Incidence and Mortality 2007. Sydney Cancer Institute NSW, December 2009.
16. Fritz AG. International Classification of Diseases for Oncology: ICD-O. Geneva: World Health Organization, 2000.
17. National Centre for Classification in Health. The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM). Lidcombe, NSW, 2010.
18. CHEREL. Centre for Health Record Linkage MLK Quality Assurance. NSW, 2011.
19. Tracey E, Barraclough H, Chen W etal. Survival from Cancer in NSW: 1980 to 2003. Sydney: Cancer Institute NSW, 2007.
20. Gomez S, Glaser S, McClure L etal. The California Neighborhoods Data System: a new resource for examining the impact of neighborhood characteristics on cancer incidence and outcomes in populations. Cancer Causes Control 2011; 22: 631-647.
21. Haynes R, Jones AP, Sauerzapf V, Zhao H. Validation of travel times to hospital estimated by GIS. Int. J. Health Geogr. 2006; 5: 40.
22. Ministry of Health. Isolated Patients Travel and Accommodation Assistance Scheme Policy Framework. North Sydney, NSW, 2012.
23. NSW Cancer Institute. Canrefer-Cancer Referral Network. Edition. NSW. [Cited 2 May 2014.] Available from URL: http://www.canrefer.org.au/
24. Akaike H. A new look at the statistical model identification. IEEE T. Automat. Contr. 1974; 19: 716-723.
25. Institute for Digital Research and Education. FAQ: What are pseudo R-squareds? Edition. UCLA. [Cited 5 Mar 2014.] Available from URL: http://www.ats.ucla.edu/stat/mult_pkg/faq/general/Psuedo_RSquareds.htm
26. Scoggins JF, Fedorenko CR, Donahue SMA, Buchwald D, Blough DK, Ramsey SD. Is distance to provider a barrier to care for Medicaid patients with breast, colorectal, or lung cancer? J. Rural Health 2012; 28: 54-62.
27. Jack RH, Gulliford MC, Ferguson J, Moller H. Geographical inequalities in lung cancer management and survival in South East England: evidence of variation in access to oncology services? Br. J. Cancer 2003; 88: 1025-1031.
28. Mitchell PL, Thursfield VJ, Ball DL etal. Lung cancer in Victoria: are we making progress? Med. J. Aust. 2013; 199: 674-679.
29. Jack RH, Gulliford MC, Ferguson J, Moller H. Explaining inequalities in access to treatment in lung cancer. J. Eval. Clin. Pract. 2006; 12: 573-582.
30. Melling PP, Hatfield AC, Muers MF etal. Lung cancer referral patterns in the former Yorkshire region of the UK. Br. J. Cancer 2002; 86: 36-42.
31. Coory M, Fong K, Bowman R, Hall L. Why we need a population-based approach to clinical indicators for cancer: a case study using microscopic confirmation of lung cancer in Queensland. Intern. Med. J. 2006; 36: 389-392.
32. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111: 1710-1717.
33. Janssen-Heijnen ML, Coebergh J-WW. Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe. Lung Cancer 2001; 31: 123-137.
34. Hall SE, Holman D, Sheiner H. The influence of socio-economic and locational disadvantage on patterns of surgical care for lung cancer in Western Australia 1982-2001. Aust. Health Rev. 2004; 27: 68-79.
35. Kaergaard Starr L, Osler M, Steding-Jessen M etal. Socioeconomic position and surgery for early-stage non-small-cell lung cancer: a population-based study in Denmark. Lung Cancer 2013; 79: 262-269.
36. Burmeister BH, Zarate DD, Burmeister EA etal. Lung cancer patients in Queensland suffer delays in receiving radiation therapy-but not as a result of distance. Inter. Med. J. 2010; 40: 126-132.